Equitable Holdings
EQH
$45.29
+0.20%
Equitable Holdings is a diversified financial services company operating primarily in the insurance and asset management sectors, providing retirement solutions, wealth management, and investment advisory services through its three core segments. The company holds a significant market position as a major provider of annuities and retirement savings plans, with its Retirement segment being the primary revenue driver, while its Asset Management segment (AllianceBernstein) offers global investment management capabilities. The current investor narrative is shaped by management's confidence in capital return, as evidenced by recent substantial share repurchase announcements, juxtaposed against a backdrop of volatile quarterly earnings performance that has sparked debate about the sustainability of its profitability and growth trajectory in a challenging interest rate environment.…
EQH
Equitable Holdings
$45.29
Related headlines
Investment Opinion: Should I buy EQH Today?
Rating & Thesis: EQH is rated a Hold. The core thesis is that while the stock appears deeply undervalued on a sales basis and management is returning capital, extreme earnings volatility and balance sheet weaknesses create too much uncertainty to warrant a Buy rating, especially given the lack of a strong analyst consensus for guidance.
Supporting Evidence: The Hold rating is supported by a low Price-to-Sales ratio of 1.22 and EV/Sales of 0.95, suggesting the stock is not expensive. Furthermore, the company generates substantial free cash flow ($737M TTM) to fund its shareholder returns. However, this is counterbalanced by deeply negative profitability (TTM net margin -11.83%), a highly leveraged balance sheet (D/E -88.68), and severe revenue volatility with a -9.5% YoY decline last quarter. The stock's technical position, trading 21% above its 52-week low, offers some margin of safety but not enough to offset the fundamental instability.
Risks & Conditions: The two biggest risks are 1) another quarter of massive investment losses eroding equity further, and 2) a deterioration in the macro environment compressing financial services multiples. This Hold would upgrade to a Buy if the company reports two consecutive quarters of positive, stable net income and the current ratio improves above 1.0. It would downgrade to a Sell if quarterly revenue falls below $2.5B or if the stock breaks below its $35.20 support level on worsening fundamentals. Relative to its own volatile history and challenged financials, the stock is fairly valued, pricing in the significant risks but offering little catalyst for multiple expansion without earnings stabilization.
Sign up to view all
EQH 12-Month Price Forecast
The 12-month outlook for EQH is one of high uncertainty with a neutral bias. The stock is a classic 'show me' story, where attractive valuation and capital return are overshadowed by fundamental instability. The base case of range-bound trading is most likely (50% probability), as the company grapples with its volatile earnings model. The stance would upgrade to bullish on evidence of sustained quarterly profitability (two consecutive quarters of net income >$150M) and an improvement in the current ratio above 0.8. It would turn bearish if the stock breaks below $35.20 on high volume or if quarterly revenue falls below $2.2B, indicating a fundamental breakdown.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $58.88 and implied upside of +30.0% versus the current price.
Average Target
$58.88
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$36 - $59
Analyst target range
Analyst coverage is extremely limited, with only 2 analysts providing estimates, indicating insufficient coverage for a robust consensus view. This minimal coverage typically suggests the stock is a mid-cap with limited institutional research interest, which can lead to higher volatility and less efficient price discovery as the market relies on fewer informed opinions. The provided data includes revenue and EPS estimates but lacks a consensus price target or Buy/Hold/Sell distribution, so a meaningful analysis of analyst sentiment and implied upside/downside cannot be conducted; investors must rely more heavily on their own fundamental and technical analysis in the absence of broad analyst scrutiny.
Bulls vs Bears: EQH Investment Factors
The bull case for EQH rests on deep value, strong capital returns, and a potential technical recovery from oversold levels, supported by high gross margins and positive cash flow. The bear case is anchored in extreme fundamental volatility, weak profitability, and a concerning balance sheet that has led to severe underperformance. Currently, the bearish evidence appears stronger due to the persistent negative earnings trend and structural financial weaknesses, which overshadow the attractive valuation. The single most important tension in the investment debate is whether management's capital return program and the high-margin business model can sustainably offset the extreme earnings volatility driven by investment marks and deliver consistent bottom-line profitability. The resolution of this tension—either through stabilized earnings or continued large swings—will dictate the stock's direction.
Bullish
- Strong Capital Return Commitment: Management has announced substantial share repurchases, signaling confidence in intrinsic value and providing a tailwind for EPS. This capital return is supported by robust TTM free cash flow of $737M, demonstrating the ability to fund buybacks internally despite earnings volatility.
- Deeply Oversold Technicals: The stock trades at $44.02, near the lower 21% of its 52-week range ($35.20-$56.61), indicating significant pessimism is priced in. Recent positive momentum, with a +18.27% 3-month gain, suggests a potential bottoming process and technical recovery is underway.
- Attractive Valuation on Sales: The stock trades at a trailing PS ratio of 1.22 and an EV/Sales of 0.95, which is near the low end of its historical range. This suggests the market is applying a modest multiple to sales, potentially pricing in excessive negativity given the company's market position.
- High Gross Margin Business Model: The company maintains a structurally high gross margin of 79.14% (TTM), indicating a strong underlying fee-based business. The latest quarterly gross margin of 88.07% demonstrates the core profitability of its insurance and asset management operations when excluding volatile investment marks.
Bearish
- Extreme Earnings Volatility: Profitability is highly unstable, with TTM net margin at -11.83% and quarterly net income swinging from a $215M profit to a $1.31B loss. This erratic performance, driven by investment-related marks, makes forecasting and valuation exceptionally difficult.
- Severe Underperformance vs. Market: The stock has a 1-year price change of -17.07%, underperforming the SPY by nearly 40 percentage points. This persistent weakness, coupled with a -37.01% max drawdown, reflects deep-seated investor concerns about the business model and growth trajectory.
- Weak Balance Sheet & Liquidity: The balance sheet shows a highly leveraged structure with a debt-to-equity ratio of -88.68 and a concerning current ratio of 0.57, indicating potential short-term liquidity constraints. Negative shareholder equity complicates traditional financial health assessment.
- Erratic Revenue & Negative Growth: Revenue is highly volatile, with Q4 2025 revenue of $3.28B representing a -9.5% YoY decline. The multi-quarter trend shows extreme inconsistency, swinging from $3.90B to $1.45B, underscoring sensitivity to market conditions and lack of predictable top-line growth.
EQH Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of -17.07%, significantly underperforming the SPY's +22.86% gain. Currently trading at $44.02, it sits near the lower end of its 52-week range of $35.20 to $56.61, positioning it at approximately 21% of this range, which suggests the stock is deeply oversold and may present a value opportunity, though it also risks being a 'falling knife' if fundamental headwinds persist. Recent momentum shows a notable divergence, with a strong 3-month gain of +18.27% and a 1-month gain of +6.87%, indicating a potential bottoming process or short-term recovery rally is underway, contrasting sharply with the longer-term downtrend. This positive short-term momentum, coupled with a beta of 1.11 indicating slightly above-market volatility, suggests the stock is attempting to stabilize after a severe drawdown of -37.01% from its highs. Key technical levels are clearly defined, with immediate resistance near the 52-week high of $56.61 and strong support at the 52-week low of $35.20; a sustained breakout above the recent recovery highs near $46-48 would signal a more durable trend reversal, while a breakdown below the $35 support could trigger another leg down, with the elevated beta implying amplified moves relative to the broader market.
Beta
1.11
1.11x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$57
Price range past year
Annual Return
-14.6%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | +1.5% |
| 3m | +19.7% | +13.4% |
| 6m | -5.2% | +10.9% |
| 1y | -14.6% | +24.5% |
| ytd | -5.6% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue growth is highly volatile and recently negative, with Q4 2025 revenue of $3.28 billion representing a -9.5% year-over-year decline, and the multi-quarter trend shows extreme inconsistency, swinging from $3.90 billion in Q1 2025 to a low of $1.45 billion in Q3 2025. This erratic revenue pattern, with a gross margin of 88.07% in the latest quarter, underscores the company's sensitivity to investment-related income and marks-to-market, making the core fee-based business stability a critical focus for investors. Profitability is equally unstable, with net income swinging from a $215 million profit in Q4 2025 to a massive $1.31 billion loss in Q3 2025, while the trailing twelve-month net margin stands at -11.83%, indicating the company is currently unprofitable on an annual basis. The gross margin remains robust at 79.14% (TTM), but operating and net margins are deeply negative, compressing from more profitable periods in 2024, highlighting significant challenges in translating high gross profits to the bottom line amid investment losses and expenses. The balance sheet shows a highly leveraged structure with a debt-to-equity ratio of -88.68, which is an unusual figure often resulting from negative shareholder equity, and a current ratio of 0.57 indicates potential short-term liquidity constraints. However, the company generates substantial operating cash flow, with free cash flow TTM of $737 million, providing internal funding for dividends and share buybacks, though the negative ROA of -0.05% signals inefficient use of assets.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$737000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Given the negative trailing net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 1.22 and a forward PS implied by analyst revenue estimates, which suggests the market is applying a modest sales multiple to a company with profitability challenges. Peer comparison is challenging due to the lack of provided industry average multiples in the data, but the EV/Sales ratio of 0.95 indicates the enterprise value is slightly below annual sales, which could be considered inexpensive for a financial services firm if sustainable profitability can be restored. The historical context reveals the current PS ratio of 1.22 is near the low end of its own historical range observed in the provided data, which has seen peaks above 12 and fluctuations between 2-10, suggesting the stock is pricing in significant pessimism or fundamental deterioration relative to its own history.
PE
-10.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -25x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-85.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: EQH faces significant financial risks stemming from extreme earnings volatility, with a TTM net margin of -11.83% and quarterly swings from a $215M profit to a $1.31B loss, making reliable forecasting nearly impossible. The balance sheet is weak, with a debt-to-equity ratio of -88.68 and a current ratio of 0.57, indicating potential liquidity strain despite $737M in TTM free cash flow. Revenue concentration in market-sensitive retirement products and erratic quarterly revenue growth (-9.5% YoY in Q4) further expose the company to economic cycles and interest rate shifts, challenging its ability to justify any valuation premium.
Market & Competitive Risks: The stock trades at a PS ratio of 1.22, which is low historically but reflects deep skepticism; however, any failure to stabilize profitability could lead to further multiple compression. With a beta of 1.11, EQH exhibits slightly above-market volatility, amplifying downside during market stress, as evidenced by its -37.01% drawdown. Competitive and regulatory pressures in the insurance and asset management sectors could squeeze margins, while the limited analyst coverage (only 2 analysts) reduces visibility and increases the risk of sudden sentiment shifts based on sparse information.
Worst-Case Scenario: The worst-case scenario involves a renewed downturn in financial markets, triggering another quarter of massive investment losses similar to Q3 2025's $1.31B net loss. This could erode capital, force a dividend cut, and halt buybacks, leading to a loss of investor confidence. Combined with its liquidity constraints (current ratio 0.57), this could pressure the stock to retest and break its 52-week low of $35.20. From the current price of $44.02, this scenario implies a realistic downside of approximately -20%. A breach of that support could trigger a steeper decline towards the $30 level, representing a total loss of over -30%.
FAQ
The key risks of holding EQH are, in order of severity: 1) Earnings Volatility Risk: The company has shown extreme quarterly swings in profitability, including a $1.31B loss in Q3 2025, making future earnings unpredictable. 2) Balance Sheet & Liquidity Risk: A debt-to-equity ratio of -88.68 and a current ratio of 0.57 indicate high leverage and potential short-term funding constraints. 3) Market & Macro Risk: With a beta of 1.11, the stock is sensitive to market downturns, and its annuity business is heavily influenced by interest rate movements. 4) Execution & Sentiment Risk: Limited analyst coverage (only 2 analysts) means negative news can lead to disproportionate selling due to a lack of institutional support and research.
The 12-month forecast for EQH is bifurcated with a wide range of outcomes due to high fundamental uncertainty. The base case (50% probability) sees the stock trading between $40 and $48 as it remains range-bound amidst volatile earnings. The bull case (25% probability), catalyzed by earnings stabilization and successful buybacks, projects a move towards $52-$56. The bear case (25% probability), triggered by another large quarterly loss, forecasts a decline to $30-$35, breaching the 52-week low. The base case is most likely, predicated on the assumption that revenue stabilizes near analyst estimates of ~$17.8B annually but profitability remains choppy, preventing a sustained re-rating.
Based on sales multiples, EQH appears undervalued. It trades at a trailing Price-to-Sales ratio of 1.22 and an EV/Sales ratio of 0.95, which is near the low end of its own historical range. This suggests the market is applying a very modest multiple, likely due to the company's profitability challenges and earnings volatility. However, traditional P/E valuation is not meaningful due to negative trailing earnings. Compared to a hypothetical sector average, the sales multiple looks cheap, but this discount is justified by the company's negative ROA (-0.05%) and erratic financial performance. The valuation implies the market expects continued operational challenges and assigns little premium for growth or stability.
EQH is a high-risk, high-potential-reward stock that is not a good buy for most conservative investors. For a speculative, value-oriented investor with a high risk tolerance, it may present an opportunity. The stock trades at a low PS ratio of 1.22 and is 21% above its 52-week low, suggesting significant bad news is priced in. However, with extreme earnings volatility (TTM net margin -11.83%), a weak balance sheet, and only 2 analyst estimates, the uncertainty is substantial. It could be a good buy only for those who believe the company can stabilize its quarterly profits and who are prepared to withstand potential further downside to the $35 support level.
EQH is not suitable for short-term trading due to its high beta (1.11) and erratic earnings, which can cause sharp, unpredictable moves around quarterly reports. For a long-term investment, it carries significant fundamental risk, but a patient investor with a 3-5 year horizon might be rewarded if management successfully navigates the volatility and returns the company to consistent profitability. The stock's profile—deep value, high cash flow, but unstable earnings—makes it a speculative holding for a long-term portfolio, not a core position. A minimum holding period of 2-3 years is suggested to allow for potential operational turnaround and multiple expansion, but investors must be prepared for high volatility throughout that period.
